Targeting renal cell carcinoma with a HIF-2 antagonist.
Nature. 2016 Nov 3;539(7627):112-117. doi: 10.1038/nature19796. Epub 2016 Sep 5.
Nature. 2016.
PMID: 27595394
Free PMC article.